Oxazoles
eMolecules Chem-Impex 1 3-Dibromo-5 5-dimethylhydantoin 50kg 462126757 24466 0 000 77-48-5 MFCD00003189 285 923 C5H6Br2N2O2
Chem-Impex 1 3-Dibromo-5 5-dimethylhydantoin 50kg 462126757 24466 0 000 77-48-5 MFCD00003189 285 923 C5H6Br2N2O2
eMolecules 5-Bromo-oxazole-2-carboxylic acid methyl ester | 2385363-22-2 | | 1g
J & W PharmLab LLC | 5-Bromo-oxazole-2-carboxylic acid methyl ester | 1g | 553408715 | 56R0682 | 95.000 | 2385363-22-2 | | 205.995 | C5H4BrNO3
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
eMolecules Key Organics/BIONET 1 3-oxazol-2-amine 1mg 564126048 FB-0707 97 000 4570-45-0 MFCD07364485 84 078 C3H4N2O
Key Organics/BIONET 1 3-oxazol-2-amine 1mg 564126048 FB-0707 97 000 4570-45-0 MFCD07364485 84 078 C3H4N2O
Selleck Chemical LLC Y-27632
Y-27632 is a selective ROCK1 and ROCK2 inhibitor with a Ki of 140 nM and 300nM in a cell-free assay exhibits 200-fold selectivity over other kinases including PKC cAMP-dependent protein kinase MLCK and PAK
Medchemexpress LLC Benzenamine, 4-(2-benzoxazolyl)- | 20934-81-0 | MFCD00453046 | 99.9% | 210.24 g/mol | C13H10N2O | 5 G
4-(Benzo[d]oxazol-2-yl)aniline is a small-molecule research compound described as a potent antitumor agent with reported inhibitory activity against mammary carcinoma cell lines. Supplied as a solid for preclinical and analytical use, it is commonly offered in laboratory pack sizes and solution formats for assay preparation.
- Small-molecule research reagent suitable for in vitro studies.
- Reported antitumor activity against mammary carcinoma cell lines.
- High purity: 99.9% (HPLC), suitable for analytical applications.
- Solid form with light yellow to brown appearance for easy handling.
- Well-characterized by molecular formula C13H10N2O and molecular weight 210.24 g/mol.
- Available in multiple pack sizes and solution formats for assay convenience.
Selleck Chemical LLC Y-27632
Y-27632 is a selective ROCK1 and ROCK2 inhibitor with a Ki of 140 nM and 300nM in a cell-free assay exhibits 200-fold selectivity over other kinases including PKC cAMP-dependent protein kinase MLCK and PAK